Skip to main content
. 2021 Jul 6;125(8):1068–1079. doi: 10.1038/s41416-021-01425-7

Fig. 1. Patterns of disease response to immune checkpoint inhibitors.

Fig. 1

Disease burden is on the x-axis and time on the y-axis. All patients begin with a level of disease burden. The subsequent patient of disease response can fall into one of five broad categories; hyperprogression, primary resistance, pseudoprogression, acquired resistance or durable response.